INmune Bio Inc. (INMB) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    INmune Bio Inc.

    NASDAQ: INMB · Real-Time Price · USD
    2.08
    -0.06 (-2.80%)
    At close: Oct 03, 2025, 3:59 PM
    2.08
    0.00%
    After-hours: Oct 03, 2025, 07:46 PM EDT

    INmune Bio Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 14K 155K 374K 181K
    Cost of Revenue
    		 n/a n/a n/a n/a
    Gross Profit
    		 14K 155K 374K 181K
    Operating Income
    		 -42.63M -29.74M -25.95M -29.15M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -42.08M -30.01M -27.3M -30.34M
    Net Income
    		 -42.08M -30.01M -27.3M -30.34M
    Selling & General & Admin
    		 9.48M 9.62M 9.26M 8.79M
    Research & Development
    		 33.17M 20.27M 17.07M 20.54M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 42.65M 29.9M 26.32M 29.33M
    Interest Expense
    		 n/a n/a 1.35M n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 42.65M 29.9M 26.32M 29.33M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 19.94M 17.98M 17.93M 16.13M
    Shares Outstanding (Diluted)
    		 19.94M 17.98M 17.93M 16.13M
    EPS (Basic)
    		 -2.11 -1.67 -1.52 -1.88
    EPS (Diluted)
    		 -2.11 -1.67 -1.52 -1.88
    EBITDA
    		 -42.08M -29.74M -25.95M -29.15M
    EBIT
    		 -42.63M -29.74M -25.95M -29.15M
    Depreciation & Amortization
    		 553K 29.74M 25.95M 29.15M

    Add to Watchlist